Targeted Therapy in Acute Myeloid Leukemia: Aim With Caution

International Journal of Hematologic Oncology - United Kingdom
doi 10.2217/ijh.12.22
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd

Related search

Oligonucleotide Aptamer-Drug Conjugates for Targeted Therapy of Acute Myeloid Leukemia

Biomaterials
Mechanics of MaterialsBiophysicsBiomaterialsBioengineeringCompositesNanoscienceNanotechnologyCeramics
2015English

Therapy of Acute Myeloid Leukemia

2012English

SHIP1 Is Targeted by miR-155 in Acute Myeloid Leukemia

Oncology Reports
MedicineCancer ResearchOncology
2014English

Therapy-Related Myelodysplasia and Acute Myeloid Leukemia

Seminars in Oncology
OncologyHematology
2013English

Acute Myeloid Leukemia Stem Cells and CD33-targeted Immunotherapy

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Optimizing Survival Outcomes With Post‐remission Therapy in Acute Myeloid Leukemia

American Journal of Hematology
Hematology
2019English

Antibody-Based Therapy of Acute Myeloid Leukemia With Gemtuzumab Ozogamicin

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2013English

“Epigenetic” Modification as Therapy for Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2017English

Acute Myeloid Leukemia Therapy and the Chosen People

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy